M. Marchioni

Papers

1

Total Citations

1

H-Index

1

About

M. Marchioni is a urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for kidney cancer treatment, particularly through robotic-assisted partial nephrectomy. Their key research areas include renal cell carcinoma management, near-infrared fluorescence imaging, and selective arterial clamping strategies to optimize oncologic outcomes while preserving renal function. Marchioni’s most notable contribution is a pioneering 2024 study demonstrating the feasibility of robotic-partial nephrectomy in cT2 patients using indocyanine green for real-time vascular mapping and selective clamping, a technique that reduces ischemia time and spares healthy tissue. This work, though early in its citation impact, represents a significant step toward expanding nephron-sparing surgery to larger, more complex tumors. Marchioni’s research bridges surgical innovation and patient-centered outcomes, offering practical solutions for challenging clinical scenarios. Their single-center results provide a foundation for broader adoption and future multicenter trials, positioning Marchioni as a rising voice in urologic oncology. With a focus on technical refinement and evidence-based practice, their contributions are poised to influence surgical standards for kidney cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of robotic-partial nephrectomy in cT2 patients with near-infrared fluorescence imaging with indocyanine green for selective arterial clamping: technical aspects and results in a single center
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago